Summary
Built a large-scale, multi-omic immune cell atlas to model human immune responses at single-cell resolution. Applied machine learning to identify and validate therapeutic targets in oncology and immunology. Supported clinical trial decision-making with data-driven insights. Aimed to reduce development risk and accelerate biopharmaceutical R&D.